Eyetek AUS + NZ, 17/35 Paringa Road, Murarrie (2026)

04/02/2026

Meibomian gland dysfunction (MGD)—a major cause of dry eye—is present in roughly 35–37% of the population globally, with some estimates reaching 1 billion people. These rapidly increasing conditions demand innovative, world-class diagnostic and therapeutic solutions.

The ESW Vision Dry Eye Managment Suite combines combines both the Tearcheck and Tearstim IRPL® into a single turnkey solution to streamline your dry eye diagnostic and therapy.
Contact Eyetek for the latest World-leading Dry Eye Solution: https://www.eyetek.com.au/dry-eye-clinic-resource.html

30/01/2026

86% of children with severe meibomian gland atrophy (MGA) reported at least 4 hours per day of electronic screen use, and 50% reported 8 hours or more per day.

As screen time soars, Meibomian Gland Atrophy is surging among younger patients. The need to screen, educate, and treat Dry Eye Disease has never been more critical.

REXON-EYE delivers contactless, hands-free treatment for both Evaporative and Aqueous Deficient DED, it is a compelling differentiator that accommodates all skin pigmentation.

Contact The Team at Eyetek to explore the best Dry eye management solution for your clinic.
https://www.eyetek.com.au/dry-eye-clinic-resource.html

28/01/2026

A study reveals approximately 90% of individuals with keratoconus report symptoms of dry eye, with a mean Ocular Surface Disease Index (OSDI) score of 40.2, indicating severe dry eye in this population.

CSO Antares+ offers Auto Keratoconus classification Screening and Contact custom lens fitting simulation based on patient topology. It also offers extensive dry eye assessment including IR meibography, Dynamic Tear Breakup Time, OSDI, Tear meniscus height and more.

Contact the Team at Eyetek to streamline your contact lens fitting, keratoconus, dry eye screening/education/treatment workflow today.

https://www.eyetek.com.au/dry-eye-clinic-resource.html

24/01/2026

DED is a multi-factorial disease. By utilizing the comprehensive diagnostic tool, you can educate your patients, diagnose symptoms, and prescribe the best possible treatment plan.

Tearcheck is an all-encompassing dry eye diagnostic and patient education tool. It uses a touch-based interface and patented examinations to diagnose and monitor dry eye diseases. It offers OSIE® (Ocular Surface Inflammatory Evaluation), TFSE® / NIBUT (Tear Film Stability Evaluation / Non-Invasive Breakup Time) | Incomplete Blink Analysis, Eye Redness, Demodex, 3D IR Meibography and OSDI questionnaire.

Contact your Team at Eyetek today to learn more about our solutions and start your dry eye services in 2026.

https://www.eyetek.com.au/contact.html

23/01/2026

Exciting Update from Rotorua Eye Clinic!

We are thrilled to announce the successful installation of the CSO MS39 and Osiris leading surgery station at Rotorua Eye Clinic, significantly advancing the clinic's capacity to deliver world-class eye care.

A heartfelt thank you to the dedicated team of leading surgeons:
Dr Marc Gimblett, Dr Derrell Meyer, Dr Malcolm Carey, Dr Colin Parsloe and Dr Malcolm Naudé

To the exceptional team at Rotorua: Thank you for your trust, collaboration, and dedication to surgical excellence. It's an honor to stand alongside you as you transform lives through the gift of sight.

21/01/2026

In Dry Eye Management, patient education is paramount. CSO Antares+ is an all-in-one topographer offering the most advanced features for dry eye management and patient education. The topography function provides information about the curvature, elevation, and refractive power of the cornea. It uses the Wavefront Aberrometry and benefits from A.I. Keratoconus auto detection.

Antares+’s extensive dry eye management features include IR Meibography Grading, OSDI Questionnaire, Dynamic NIBUT analysis with playback features for patient education, lipid layer grading, infrared meibography and pupillography. The Topographer also comes with an advanced auto-fit contact lens module, which allows practitioners to simulate the fitting of Ortho-K and custom lenses.

Contact your Team at Eyetek today to learn more about our solutions and start your dry eye services in 2026.

https://www.eyetek.com.au/contact.html

16/01/2026

As dry eye disease prevalence continues to rise, proactive patient education about DED becomes crucial before irreversible gland atrophy occurs. IRPL® Intense Regulated Pulsed Light offers a gold standard treatment approach that effectively addresses a wide spectrum of DED symptoms.

Clinically backed by a vast array of papers, The ESW Vision IRPL® patented technology is the established gold standard when it comes to dedicated DED treatment, IRPL® technology offers consistency and efficacy of treatment.

The regulated pulse light treatment is an enhancement to generic IPL, it maintains consistent energy levels across sub pulses, eliminating the energy degradation and output variability commonly associated with generic IPL devices.

To learn more about world leading Tearstim IRPL® Technology from ESW Vision France, contact your Team at Eyetek: https://www.eyetek.com.au/dry-eye-clinic-resources.html

14/01/2026

Meibomian Gland Dysfunction (MGD) affects up to one billion people worldwide and represents a leading cause of evaporative dry eye disease. These rapidly increasing conditions demand innovative, world-class diagnostic and therapeutic solutions.

Contact Eyetek for the latest World-leading Dry Eye Solution: https://www.eyetek.com.au/dry-eye-clinic-resources.html

09/01/2026

As dry eye disease prevalence continues to grow, early intervention is everything. Before gland atrophy becomes irreversible. Tearstim IRPL® Intense Regulated Pulsed Light offers a Gold Standard treatment approach that effectively addresses a wide spectrum of Dry Eye Disease symptoms.

IRPL® Intense Regulated Pulsed Light delivers the gold standard in dry eye therapy, backed by extensive clinical research. ESW Vision's patented IRPL® technology sets the benchmark for dedicated DED treatment, providing unmatched consistency and proven results.

Unlike generic IPL that suffer from energy degradation and output variability, IRPL® maintains precise, regulated energy levels throughout each pulse sequence. Combined with specialized light spectrum filter designed exclusively for the treatment of DED, you get targeted, efficient and effective treatment outcome.

To learn more about world leading Tearstim IRPL® Technology from ESW Vision France, contact your Team at Eyetek: https://www.eyetek.com.au/dry-eye-clinic-resources.html

07/01/2026

Meibomian gland dysfunction (MGD)—a major cause of dry eye—is present in roughly 35–37% of the population globally, with some estimates reaching 1 billion people. These rapidly increasing conditions demand innovative, world-class diagnostic and therapeutic solutions.

The ESW Vision Dry Eye Managment Suite combines combines both the Tearcheck and Tearstim IRPL® into a single turnkey solution to streamline your dry eye diagnostic and therapy.
Contact Eyetek for the latest World-leading Dry Eye Solution: https://www.eyetek.com.au/dry-eye-clinic-resources.html

02/01/2026

Groundbreaking pediatric research has revealed a concerning prevalence of meibomian gland atrophy among children aged 4 to 17. The research documented that 42% of participants exhibited signs of atrophy.

As MGD continues its growing prevalence within younger demographics, education and Meibomian assessment is key to prevent further gland atrophy and other ocular surface diseases.

ESW Vision Tearcheck is a comprehensive dry eye diagnostic and patient education tool. It utilises a touch-based interface and patented examinations to diagnose and monitor dry eye diseases. The device offers and extensive list of examinations to suit your workflow: OSIE® (Ocular Surface Inflammatory Evaluation), TFSE® / NIBUT (Tear Film Stability Evaluation / Non-Invasive Breakup Time) | Incomplete Blink Analysis, Eye Redness, Demodex, 3D IR Meibography and OSDI questionnaire.

Contact the Team at Eyetek to streamline your dry eye screening/education/treatment workflow and start screening and educating your patients before it is irreversible.

https://www.eyetek.com.au/dry-eye-clinic-resource.html

Eyetek AUS + NZ

04/02/2026

30/01/2026

28/01/2026

24/01/2026

23/01/2026

21/01/2026

16/01/2026

14/01/2026

09/01/2026

07/01/2026

02/01/2026

Address

Telephone

Website

Alerts

Shortcuts

Share

Category